Press Releases Qiagen N.V. Swiss Exchange

Equities

QGEN

NL0015001WM6

Market Closed - Swiss Exchange Other stock markets 11:35:20 2019-06-28 EDT			5-day change	1st Jan Change
39.45 ^CHF	+0.84%		-.--%	-.--%

05-15	Qiagen's Updated Clinical Decision Support Platform Secures EU Certification	MT
05-14	QIAGEN Receives European IVDR Certification for QIAGEN Clinical Insight Interpret	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical device software for clinical decision support	05-14	AQ
Qiagen N : 2023 Annual Report 2023 Sustainability Statement	05-13	PU
QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accurate results	05-13	AQ
Qiagen N : 2024 QIAGEN N.V. Annual General Meeting of Shareholders Presentation	05-08	PU
Qiagen N : 2023 Annual Report 2023 Annual Financial Report	05-08	PU
QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics	05-07	AQ
Qiagen N : Q1 2024 Results Investor Introduction	05-03	PU
Qiagen N : Virtual Berenberg MDx Day Investor Introduction	05-02	PU
QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applications	05-02	AQ
Qiagen N : First Quarter 2024 SEC Filing	05-02	PU
Q1 2024 Results Conference Call Presentation: April 30, 2023	04-30	PU
Qiagen N : QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance	04-30	PU
Q1 2024 Results Press Release: April 29, 2024, 22:05 CET	04-29	PU
Qiagen: Q1 Earnings Snapshot	04-29	AQ
QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance	04-29	AQ
Qiagen N : 2023 Annual Report 2023 IFRS Annual Report	04-25	PU
QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistance	04-24	AQ
QIAGEN N.V. to release results for Q1 2024 and hold webcast	04-09	AQ
Qiagen N : launches new solution for screening of sexual assault forensic casework samples	04-04	PU
QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024	04-03	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

QIAGEN : A decent start to 2024; guidance unchanged

April 30, 2024 at 09:32 am